Botox Approved in UK as Preventative Treatment in Chronic Migraine; First License Worldwide for This Indication

July 9 (Reuters) - Britain has become the first country to approve Allergan Inc's (AGN.N) anti-wrinkle injection Botox as a treatment for migraine, opening up a new market for the product.